Article
Identification of a novel point mutation in platelet glycoprotein Ibalpha, Gly to Ser at residue 233, in a Japanese family with platelet-type von Willebrand disease.
Journal of thrombosis and haemostasis : JTH - 1 Oct 2003
Matsubara Y, Murata M, Sugita K, Ikeda Y
Abstract excerpt
BACKGROUND: Interaction between platelet glycoprotein (GP)Ibalpha and von Willebrand factor (VWF) has critical roles in both physiological hemostasis and thrombosis. Platelet-type von Willebrand disease (plt-VWD) is a congenital bleeding disorder characterized by gain-of-function mutations of GPIbalpha. To date, two mutations in GPIbalpha, G233V and M239V, have been reported in four unrelated families with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
